BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38743625)

  • 1. Genome-wide CRISPR screens in spheroid culture reveal that the tumor suppressor LKB1 inhibits growth via the PIKFYVE lipid kinase.
    Ferrarone JR; Thomas J; Unni AM; Zheng Y; Nagiec MJ; Gardner EE; Mashadova O; Li K; Koundouros N; Montalbano A; Mustafa M; Cantley LC; Blenis J; Sanjana NE; Varmus H
    Proc Natl Acad Sci U S A; 2024 May; 121(21):e2403685121. PubMed ID: 38743625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LKB1 suppresses growth and promotes the internalization of EGFR through the PIKFYVE lipid kinase.
    Ferrarone JR; Thomas J; Unni AM; Zheng Y; Nagiec MJ; Gardner EE; Mashadova O; Li K; Koundouros N; Montalbano A; Mustafa M; Cantley LC; Blenis J; Sanjana NE; Varmus H
    bioRxiv; 2023 Oct; ():. PubMed ID: 37904985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC.
    Hollstein PE; Eichner LJ; Brun SN; Kamireddy A; Svensson RU; Vera LI; Ross DS; Rymoff TJ; Hutchins A; Galvez HM; Williams AE; Shokhirev MN; Screaton RA; Berdeaux R; Shaw RJ
    Cancer Discov; 2019 Nov; 9(11):1606-1627. PubMed ID: 31350328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung Cancer.
    Shukuya T; Yamada T; Koenig MJ; Xu J; Okimoto T; Li F; Amann JM; Carbone DP
    J Thorac Oncol; 2019 Jun; 14(6):1061-1076. PubMed ID: 30825612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An LKB1-SIK Axis Suppresses Lung Tumor Growth and Controls Differentiation.
    Murray CW; Brady JJ; Tsai MK; Li C; Winters IP; Tang R; Andrejka L; Ma RK; Kunder CA; Chu P; Winslow MM
    Cancer Discov; 2019 Nov; 9(11):1590-1605. PubMed ID: 31350327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
    Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
    Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer.
    Liu Y; Marks K; Cowley GS; Carretero J; Liu Q; Nieland TJ; Xu C; Cohoon TJ; Gao P; Zhang Y; Chen Z; Altabef AB; Tchaicha JH; Wang X; Choe S; Driggers EM; Zhang J; Bailey ST; Sharpless NE; Hayes DN; Patel NM; Janne PA; Bardeesy N; Engelman JA; Manning BD; Shaw RJ; Asara JM; Scully R; Kimmelman A; Byers LA; Gibbons DL; Wistuba II; Heymach JV; Kwiatkowski DJ; Kim WY; Kung AL; Gray NS; Root DE; Cantley LC; Wong KK
    Cancer Discov; 2013 Aug; 3(8):870-9. PubMed ID: 23715154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
    Memmott RM; Gills JJ; Hollingshead M; Powers MC; Chen Z; Kemp B; Kozikowski A; Dennis PA
    Cancer Res; 2008 Jan; 68(2):580-8. PubMed ID: 18199555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LKB1 inhibits telomerase activity resulting in cellular senescence through histone lactylation in lung adenocarcinoma.
    Liu M; Gu L; Zhang Y; Li Y; Zhang L; Xin Y; Wang Y; Xu ZX
    Cancer Lett; 2024 Jul; 595():217025. PubMed ID: 38844063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rab3B enhances the stabilization of DDX6 to promote lung adenocarcinoma aggressiveness.
    Yao G; Yu S; Hou F; Xiao Z; Li G; Ji X; Wang J
    Mol Med; 2024 Jun; 30(1):75. PubMed ID: 38834947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic liver kinase B1 promotes the growth of human lung adenocarcinoma by enhancing autophagy.
    Liu M; Jiang L; Fu X; Wang W; Ma J; Tian T; Nan K; Liang X
    Cancer Sci; 2018 Oct; 109(10):3055-3067. PubMed ID: 30033530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMPKα-like proteins as LKB1 downstream targets in cell physiology and cancer.
    Molina E; Hong L; Chefetz I
    J Mol Med (Berl); 2021 May; 99(5):651-662. PubMed ID: 33661342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in non-small-cell lung cancer (NSCLC) cells.
    Whang YM; Park SI; Trenary IA; Egnatchik RA; Fessel JP; Kaufman JM; Carbone DP; Young JD
    Oncogene; 2016 Feb; 35(7):856-66. PubMed ID: 26119936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids.
    Peart T; Ramos Valdes Y; Correa RJ; Fazio E; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Oncotarget; 2015 Sep; 6(26):22424-38. PubMed ID: 26068970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LKB1 in lung cancerigenesis: a serine/threonine kinase as tumor suppressor.
    Gao Y; Ge G; Ji H
    Protein Cell; 2011 Feb; 2(2):99-107. PubMed ID: 21380642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPK-Independent LKB1 Activity Is Required for Efficient Epithelial Ovarian Cancer Metastasis.
    Buensuceso A; Ramos-Valdes Y; DiMattia GE; Shepherd TG
    Mol Cancer Res; 2020 Mar; 18(3):488-500. PubMed ID: 31744879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnosic Acid against Lung Cancer: Induction of Autophagy and Activation of Sestrin-2/LKB1/AMPK Signalling.
    O'Neill EJ; Sze NSK; MacPherson REK; Tsiani E
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of tumor suppression by LKB1.
    Vaahtomeri K; Mäkelä TP
    FEBS Lett; 2011 Apr; 585(7):944-51. PubMed ID: 21192934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STK11/LKB1 alterations worsen the poor prognosis of KRAS mutated early-stage non-squamous non-small cell lung carcinoma, results based on the phase 2 IFCT TASTE trial.
    Baptiste Oudart J; Garinet S; Leger C; Barlesi F; Mazières J; Jeannin G; Audigier-Valette C; Morot-Sibilot D; Langlais A; Amour E; Mathiot N; Birsen G; Blons H; Wislez M
    Lung Cancer; 2024 Apr; 190():107508. PubMed ID: 38428265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Deoxyglucose Suppresses ERK Phosphorylation in LKB1 and Ras Wild-Type Non-Small Cell Lung Cancer Cells.
    Sun L; Liu X; Fu H; Zhou W; Zhong D
    PLoS One; 2016; 11(12):e0168793. PubMed ID: 28033353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.